Clinical Trial

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

Study acronym: PATHFINDER
Recruiting
View on ClinicalTrials.gov →
Summary
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-29
notable Trial sites expanded: 0 -> 4 locations 2026-07-29
Trial Details
NCT Number NCT07321899
Lead Sponsor Medtronic Cardiovascular
Conditions Severe Tricuspid Regurgitation
Enrollment 1,186 participants
Start Date 2026-08
Primary Completion 2031-09 (estimated)
Study Completion 2041-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-28